However, as expected, since tumour cells mainly rely on the downstream metabolites generated by the serine synthesis pathway, we did detect a significant NKX2–1 associated increase in downstream GSH levels accompanied by a decrease in l-cysteine, one of the building blocks of GSH, thereby recapitulating our in vitro observations (Fig. 6b). The gene discussed is NKX2-1; the disease is neoplasm.